Looking to sell Maven Clinic stock or options?
Maven Clinic is the creator of an innovative digital health platform that enhances care for women and families, resulting in superior outcomes and reduced costs for all. The company's platform facilitates appointment scheduling with a range of healthcare professionals, including nurses, gynecologists, mental health experts, physical therapists, and nutritionists. It provides committed care and leverages data-driven insights, allowing people to access stress-free healthcare services.
Company Ventures, Female Founders Fund, Susan Lyne, Mindy Kaling, Anthro Ventures, Matthew Mullenweg, MontBlu Capital, Oak HC/FT, Aletta Angels, Harmony Partners, Anne Wojcicki, Great Oaks Venture Capital, Colle Capital Partners, Intermountain Ventures, KF20 Capital, David Chan, Loric Ventures, Sax Capital, NextGen Venture Partners, Portfolia, Fine Day Ventures, Chrysanthos Chrysanthou, Thomas Lehrman, General Catalyst, StepStone Group.
Maven Clinic is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Maven Clinic stock. Depending on Maven Clinic’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Maven Clinic stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Maven Clinic stock in two ways. First, Maven Clinic employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Maven Clinic stock. Note that all transactions in Maven Clinic shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Maven Clinic stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Maven Clinic stock. Typically, shares of private companies like Maven Clinic are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Oct 2024, Maven Clinic is reported to have closed an equity financing in which the investors valued the company at $1.7B. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Maven Clinic shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Maven Clinic is not currently publicly traded, it does not have a ticker symbol.
Maven Clinic has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Maven Clinic is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Maven Clinic shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.
Female Founders Fund has returned its first fund after doing a partial secondary sale in women’s health-focused Maven.
Kristina Campbell, Maven's former chief financial officer, has left the women's health startup on the heels of its $125 million Series F fundraise.
Maven Clinic's $125 million Series F funding round was led by StepStone Group and included participation from existing investors General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group and Lux Capital.
Founder Kate Ryder says there's still room to grow in women's health.
/PRNewswire/ -- Report with the AI impact on market trends- The global femtech devices market size is estimated to grow by USD 8.6 billion from 2024-2028,...
Sequoia-backed startup Maven is set to raise fresh funding at a $1.7 billion valuation from PE firm, StepStone Group, Business Insider has learned.
AT&T strengthens its partnership with Maven Clinic, offering its 125,000 employees expanded access to virtual fertility and family-building services. Maven’s... Continue Reading
AT&T employees can access providers across more than 35 specialties, receive support from a care advocate, and access guidance around IVF, surrogacy, and more.
Employees of Maven will have access to WellTheory's platform for individuals with autoimmune diseases, including a collaborative care team and ongoing guidance.
Maven Clinic Study Highlights Effectiveness of Virtual Doula Care in Maternal Health